Clinical significance of renal allograft biopsies with 'borderline changes,' as defined in the Banff Schema

Transplantation

Volumn 64, Issue 7, 1997, Pages 992-995

  Saad, Reda ^a,c   Gritsch, Hans A ^a   Shapiro, Ron ^b   Jordan, Mark ^a   Vivas, Carlos ^a   Scantlebury, Velma ^b   Demetris, Anthony J ^a   Randhawa, Parmjeet S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID; TACROLIMUS;

ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY; CREATININE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0030880123     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199710150-00010     Document Type: Article

References (15)

1. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
2. Schweitzer EJ, Drachenberg CB, Anderson L. Significance of the Banff borderline biopsy. Am J Kidney Dis 1996; 28: 585.
3. Gaber LW, Moore LW, Alloway RR, Flax S, Gaber AO. Correlation between Banff classification, acute renal rejection scores, and reversal of rejection. Transplant Proc 1995; 27: 1019.
4. Dooper MM, Hoitsma AJ, Koene RAP, Bogman MJJT. Evaluation of the Banff criteria for the histological diagnosis of rejection in renal allograft biopsies. Transplant Proc 1995; 27: 1005.
5. Solez K, Benediktsson H, Cavallo T. Report of the third Banff conference on allograft pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 1996; 28: 441.
6. D'Ardenne AJ, Dunnill MS, Thompson JF, McWhinnie D, Wood RFM, Morris PJ. Cyclosporine and renal graft histology. J Clin Pathol 1986; 39: 145.
7. Solez K, Racusen LC, Marcussen N. Morphology of ischemic acute renal failure, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int 1993; 43: 1058.
8. Burdick JF, Beschorner WE, Smith WJ. Characteristics of early routine renal allograft biopsies. Transplantation 1984; 38: 679.
9. Neild GH, Taube DH, Hartley RB. Morphological differentiation between rejection and cyclosporine nephrotoxicity in renal allografts. J Clin Pathol 1986; 39: 152.
10. Matas AJ, Sibley R, Mauer SM. Pre-discharge, post-transplant kidney biopsy does not predict rejection. J Surg Res 1982; 32: 269.
11. Herbertson BM, Evans DB, Calne RY, Banerjee AK. Percutaneous needle biopsies of renal allografts: the relationship between morphological changes present in biopsies and subsequent allograft function. Histopathology 1977; 1: 161.
12. Kiaer H, Hansen HE, Olsen S. The predictive value of percutaneous biopsies from human renal allografts with early impaired function. Clin Nephrol 1980; 13: 58.
13. Banfi G, Imbasciati E, Tarantino A, Ponticelli C. Prognostic value of renal biopsy in acute rejection of kidney transplantation. Nephron 1981; 28: 222.
14. Hsu AC, Arbus GS, Noriega E, Huber J. Renal allograft biopsy: a satisfactory adjunct for predicting renal function after graft rejection. Clin Nephrol 1976; 5: 260.
15. Rush D, Jeffery J, Trpkov K, Solez K, Gough J. Effect of subclinical rejection on renal allograft histology and function at 6 months. Transplant Proc 1996; 28: 494.